On 10 September 2017 Ancon became a corporate member of the Aerosol Society in the UK.
Published paper: Counting individual ions in the air by tagging them with particles. B. Gorbunov 20 May 2017 Chemical Physics 492 (2017) 1–4
360dx.com : Ancon Medical moved one step closer to launching its disease biomarker identification technology after announcing that its NBT demonstrated higher sensitivity in detecting signs of disease than a conventional method.
A series of laboratory tests have verified the sensitivity and accuracy of the revolutionary health screening technology developed by Ancon that detects the signs of
In what would be a breakthrough in the home health screening market, Ancon Medical, Inc. has developed its revolutionary disease screening technology for a home
The rapid spread of the Zika virus is elevating concern across the globe and one issue facing health officials is the absence of a simple, quick process to detect the infection, raising the chances the disease could spread.
With its NBT technology, Ancon Medical can give healthcare providers a versatile disease screening device that delivers a wide range of features, including unmatched sensitivity, portability and fast results accessible to much wider range of the population.
After 15 years of research and development by Ancon Medical on revolutionary disease screening technology, the Minnesota-based company has developed a cutting-edge medical device that
November was Lung Cancer Awareness Month and healthcare advocates like the American Lung Association used the event to press for additional research, improved early detection,
Ancon Medical, Inc., recently designed a non-invasive screening tool sensitive enough to detect lung cancer in its earliest stage, while costing significantly less than conventional